Market Cap 82.71M
Revenue (ttm) 0.00
Net Income (ttm) -115.86M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,703,500
Avg Vol 2,307,554
Day's Range N/A - N/A
Shares Out 50.74M
Stochastic %K 38%
Beta 2.70
Analysts Strong Sell
Price Target $15.89

Company Profile

Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with autoimmune diseases. Its lead product candidate is resecabtagene autoleucel, a 4-1BB co-stimulatory domain-containing fully human CD19-CAR T, which is in Phase 1/2 clinical trials for the treatment of dermatomyositis, anti-synthetase syndrome, immune-mediated necrotizing myopathy, juvenile myositis, lupus nephritis, non-renal systemic lupus erythe...

Industry: Biotechnology
Sector: Healthcare
Phone: 267 759 3100
Address:
2929 Arch Street, Suite 600, Philadelphia, United States
WastedTrader
WastedTrader Jul. 8 at 12:24 AM
$CABA im still here! Not gonna lie, I hope this tanks below a dollar so I can buy 15k shares on the cheap 💪 stay strong bulls ✅️ long haul 💯, everyone wants to get rich quick, 15X your money in 2 years beats any common investment
0 · Reply
MarmotStock
MarmotStock Jul. 7 at 11:42 PM
$CABA Next catalyst: 26-week durability read-out at ACR Convergence, 24 Oct 2025, and it is worth noting that biotechnology stocks often experience their squeezes 30 to 60 days in advance of such events. This is an important point to watch closely.
0 · Reply
Liveanddiebythethree
Liveanddiebythethree Jul. 7 at 7:38 PM
$CABA when is this going to hit? Later this year? What’s the next anticipated catalyst.
1 · Reply
Yoety
Yoety Jul. 7 at 7:12 PM
$CABA Big pile of poos, just dead money so far & it’s been for whiles now. F’n hard to hold!
0 · Reply
Moonman321
Moonman321 Jul. 7 at 5:45 PM
$CABA I know the way these money pigs work I worked in the industry Stock manipulation is a real thing They can play all the games they want This will take off. It’s just a matter of time. They’ll shake the tree as much as they can the undeserving will be left behind Don’t fight the fed Rate cuts incoming Small cap heaven
0 · Reply
ThomasTrainTrader
ThomasTrainTrader Jul. 7 at 4:35 PM
$KYTX I don’t even say this to shit on $CABA as in the grand scheme of things it seems also undervalued, but I have yet to have anyone give me an answer as to why it is a better buy than Kyverna in any way, shape, or form other than the fact that it is a traditional meme stock that has more volume
1 · Reply
ThomasTrainTrader
ThomasTrainTrader Jul. 7 at 4:30 PM
$KYTX Has enough cash to purchase the entire company of $CABA twice btw. Also has a more developed pipeline and leaders who have scaled manufacturing profitably. Yet is valued at $22 million less than CABA 😭
0 · Reply
Daydreamer8
Daydreamer8 Jul. 7 at 3:37 PM
$CABA bought🌈
0 · Reply
Moonman321
Moonman321 Jul. 7 at 3:25 PM
$CABA holding long on this one just snapped up a nice buy right here
0 · Reply
Moonman321
Moonman321 Jul. 6 at 5:37 PM
$CABA I decided one more $30,000 purchase tomorrow morning The upside on this is tremendous and will happen Don’t say those famous words I wish I would’ve bought more
1 · Reply
Latest News on CABA
Cabaletta Bio: Sector Headwinds And Funding Issues

Jun 11, 2025, 9:49 AM EDT - 26 days ago

Cabaletta Bio: Sector Headwinds And Funding Issues


Cabaletta Bio Announces Proposed Public Offering of Securities

Jun 11, 2025, 6:15 AM EDT - 26 days ago

Cabaletta Bio Announces Proposed Public Offering of Securities


Cabaletta Bio: Finding Optimism In Dire Straits

Jan 6, 2025, 2:28 PM EST - 6 months ago

Cabaletta Bio: Finding Optimism In Dire Straits


Cabaletta Bio: Next Data Readout Needs To Be Mic Drop Moment

Jun 28, 2024, 1:42 PM EDT - 1 year ago

Cabaletta Bio: Next Data Readout Needs To Be Mic Drop Moment


Cabaletta Bio: Expanding The Success Of CAR-T Beyond Oncology

Dec 11, 2023, 5:58 AM EST - 1 year ago

Cabaletta Bio: Expanding The Success Of CAR-T Beyond Oncology


Buy Cabaletta Bio's Promising SLE Treatment

Dec 10, 2023, 2:44 AM EST - 1 year ago

Buy Cabaletta Bio's Promising SLE Treatment


Cabaletta Bio to Present at the Jefferies Healthcare Conference

May 31, 2023, 8:00 AM EDT - 2 years ago

Cabaletta Bio to Present at the Jefferies Healthcare Conference


Cabaletta Bio: Speculative Biotech With Opportunity

Apr 27, 2023, 4:49 PM EDT - 2 years ago

Cabaletta Bio: Speculative Biotech With Opportunity


WastedTrader
WastedTrader Jul. 8 at 12:24 AM
$CABA im still here! Not gonna lie, I hope this tanks below a dollar so I can buy 15k shares on the cheap 💪 stay strong bulls ✅️ long haul 💯, everyone wants to get rich quick, 15X your money in 2 years beats any common investment
0 · Reply
MarmotStock
MarmotStock Jul. 7 at 11:42 PM
$CABA Next catalyst: 26-week durability read-out at ACR Convergence, 24 Oct 2025, and it is worth noting that biotechnology stocks often experience their squeezes 30 to 60 days in advance of such events. This is an important point to watch closely.
0 · Reply
Liveanddiebythethree
Liveanddiebythethree Jul. 7 at 7:38 PM
$CABA when is this going to hit? Later this year? What’s the next anticipated catalyst.
1 · Reply
Yoety
Yoety Jul. 7 at 7:12 PM
$CABA Big pile of poos, just dead money so far & it’s been for whiles now. F’n hard to hold!
0 · Reply
Moonman321
Moonman321 Jul. 7 at 5:45 PM
$CABA I know the way these money pigs work I worked in the industry Stock manipulation is a real thing They can play all the games they want This will take off. It’s just a matter of time. They’ll shake the tree as much as they can the undeserving will be left behind Don’t fight the fed Rate cuts incoming Small cap heaven
0 · Reply
ThomasTrainTrader
ThomasTrainTrader Jul. 7 at 4:35 PM
$KYTX I don’t even say this to shit on $CABA as in the grand scheme of things it seems also undervalued, but I have yet to have anyone give me an answer as to why it is a better buy than Kyverna in any way, shape, or form other than the fact that it is a traditional meme stock that has more volume
1 · Reply
ThomasTrainTrader
ThomasTrainTrader Jul. 7 at 4:30 PM
$KYTX Has enough cash to purchase the entire company of $CABA twice btw. Also has a more developed pipeline and leaders who have scaled manufacturing profitably. Yet is valued at $22 million less than CABA 😭
0 · Reply
Daydreamer8
Daydreamer8 Jul. 7 at 3:37 PM
$CABA bought🌈
0 · Reply
Moonman321
Moonman321 Jul. 7 at 3:25 PM
$CABA holding long on this one just snapped up a nice buy right here
0 · Reply
Moonman321
Moonman321 Jul. 6 at 5:37 PM
$CABA I decided one more $30,000 purchase tomorrow morning The upside on this is tremendous and will happen Don’t say those famous words I wish I would’ve bought more
1 · Reply
Moonman321
Moonman321 Jul. 6 at 5:32 PM
$CABA no risk no reward 😆 Find my fourth round tomorrow it’s going be a good week
0 · Reply
MiroslavBroz
MiroslavBroz Jul. 5 at 4:23 PM
$CABA Just so you know, CABA is also heard of in Croatia (4 million people)
0 · Reply
MiroslavBroz
MiroslavBroz Jul. 5 at 4:18 PM
0 · Reply
YasirTrades
YasirTrades Jul. 5 at 3:26 AM
GLMD is running out of time in a good way. The 90-day definitive agreement window from April 28th ends this month. You don’t get many biotech plays under $1 with a $12+ book value and real M&A potential. Low float, strong cash, and a clear catalyst. It’s a ticking time bomb in a setup kind of way. $CABA $ALLR $CNTB $CLRB
0 · Reply
MarmotStock
MarmotStock Jul. 3 at 7:09 PM
$CABA CABA no longer faces any immediate dilution risk, as it has concluded its share issuance agreements. On the contrary, the company is approaching a significant catalyst, and it is worth noting that biotechnology stocks often experience their squeezes 30 to 60 days in advance of such events. This is an important point to watch closely!!! 🔨
1 · Reply
PeterMarksMD
PeterMarksMD Jul. 3 at 6:45 PM
$CABA always the risk of more dilution.
2 · Reply
Drugtrade
Drugtrade Jul. 2 at 6:37 PM
$CABA mc below cash, diverse pipeline.. tech is hit or miss. Put on short term 50/50 trade idea list. Would not add more than few 100 share to long port for now
0 · Reply
Moongal123
Moongal123 Jul. 2 at 1:30 PM
$CABA Lets go
0 · Reply
KNCourt24
KNCourt24 Jul. 2 at 4:14 AM
$CABA PT still $10+
0 · Reply
JackMiHoff
JackMiHoff Jul. 2 at 2:06 AM
$CABA Been a great short
0 · Reply
Moonman321
Moonman321 Jul. 1 at 4:31 PM
$QBTS $CABA $CABA on the move!! Don’t fight the fed The fed will be cutting
0 · Reply
maybekhadgar
maybekhadgar Jul. 1 at 4:22 PM
$CABA 🙌
0 · Reply